MR-proADM as Prognostic Factor of Outcome in COVID-19 Patients.

Paolo Cameli,Elena Pordon,Miriana d'Alessandro, Maria Laura Marzi,Lucrezia Galasso,Cesare Biuzzi,Laura Bergantini,Elena Bargagli,Sabino Scolletta,Federico Franchi

Biomedicines（2023）

引用 26|浏览2

暂无评分

摘要

Our data sustain the potential of serum MR-proADM as a reliable prognostic biomarker of hospitalized COVID-19 patients and confirms the utility of the three markers in the management and risk stratification of hospitalized patients. The markers are collected mini-invasively and are quick to analyze and cost-effective.

查看译文

关键词

COVID-19, KL-6, biomarkers, proADM

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要